Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.

[1]  A. Carayon,et al.  Candidemia in critically ill patients: difference of outcome between medical and surgical patients , 2003, Intensive Care Medicine.

[2]  Kara E. Flavin,et al.  Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. , 2003, Chest.

[3]  Y. Mehta,et al.  Ventilator-associated pneumonia: Incidence, risk factors, outcome, and microbiology. , 2003, Journal of cardiothoracic and vascular anesthesia.

[4]  M. Niederman.  Appropriate use of antimicrobial agents: Challenges and strategies for improvement , 2003, Critical care medicine.

[5]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[6]  Jean-Yves Fagon,et al.  Ventilator-associated pneumonia. , 2002, American journal of respiratory and critical care medicine.

[7]  M. Bonten,et al.  Ventilator-associated pneumonia: recent issues on pathogenesis, prevention and diagnosis. , 2001, The Journal of hospital infection.

[8]  S. Fiel,et al.  Guidelines and critical pathways for severe hospital-acquired pneumonia. , 2001, Chest.

[9]  H. Dupont,et al.  Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia , 2001, Intensive Care Medicine.

[10]  M. Kollef,et al.  Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Torres,et al.  Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. , 2000, American journal of respiratory and critical care medicine.

[12]  A. Harris,et al.  Control group selection is an important but neglected issue in studies of antibiotic resistance. , 2000, Annals of internal medicine.

[13]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[14]  G Sherman,et al.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.

[15]  J. Rello,et al.  Mortality as an Outcome in Hospital-Acquired Pneumonia , 1998, Infection Control & Hospital Epidemiology.

[16]  R. Hamill,et al.  Ventilator-associated pneumonia. , 1998, International journal of antimicrobial agents.

[17]  J. Carlet,et al.  Antibiotic resistance problems in the critical care unit. , 1998, Critical care clinics.

[18]  A. Vuagnat,et al.  Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. , 1998, American journal of respiratory and critical care medicine.

[19]  M. Niederman,et al.  Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. , 1998, American journal of respiratory and critical care medicine.

[20]  M. Kollef,et al.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. , 1998, Chest.

[21]  J. Rello,et al.  The value of routine microbial investigation in ventilator-associated pneumonia. , 1997, American journal of respiratory and critical care medicine.

[22]  F. V. van Tiel,et al.  Indications for antibiotic use in ICU patients: a one-year prospective surveillance. , 1997, The Journal of antimicrobial chemotherapy.

[23]  M. Niederman,et al.  Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. , 1997, Chest.

[24]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[25]  J. Dumon,et al.  Effect of ventilator-associated pneumonia on mortality and morbidity. , 1996, American journal of respiratory and critical care medicine.

[26]  ICU-Acquired Pneumonia Study Group,et al.  Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit , 1996, Intensive Care Medicine.

[27]  A. Vuagnat,et al.  Nosocomial pneumonia and mortality among patients in intensive care units , 1996 .

[28]  M. Kollef,et al.  The effect of late-onset ventilator-associated pneumonia in determining patient mortality. , 1995, Chest.

[29]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[30]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[31]  R. Gaynes,et al.  Antibiotic resistance in ICUs: a multifaceted problem requiring a multifaceted solution. , 1995, Infection control and hospital epidemiology.

[32]  Ge Dl.  Epidemiology of nosocomial pneumonia in intensive care unit patients. , 1995 .

[33]  P. Montravers,et al.  Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. , 1993, The American journal of medicine.

[34]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[35]  J. Rello,et al.  Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. , 1991, Chest.

[36]  R. Rodríguez-Roisín,et al.  Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. , 1990, The American review of respiratory disease.

[37]  M. Guiguet,et al.  Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. , 1988, The American review of respiratory disease.

[38]  M A Barry,et al.  Nosocomial infection and fatality in medical and surgical intensive care unit patients. , 1988, Archives of internal medicine.

[39]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[40]  T. Fabian,et al.  Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. , 2005, The Journal of trauma.